Masimo MASI announced
today a new study in Respiratory Physiology & Neurobiology shows that
noninvasive carboxyhemoglobin (SpCO®) and methemoglobin (SpMet®) measurements
with Masimo rainbow® Pulse CO-Oximetry™ are accurate and conclude they can be
used as an effective first screening test with emergency room patients
suspected of suffering carbon monoxide (CO) poisoning.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in